Oncology November 2011

Oncology November 2011

REMS in Oncology

The Food and Drug Administration Amendments Act, a landmark legislation that created a new standard for drug safety and pharmacovigilance, was passed in 2007.

Therapeutic Application of Pharmacogenomics in Oncology: Selective Biomarkers for Cancer Treatment

Targeted therapy guided by PGx biomarkers has the potential to significantly improve the prognosis of selective cancer patients. 

Continuing Education

$7.95 Per CE Exam or $69 for 12 Lessons